Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 7/20 | 0.61 |
| ▸ | RXRA | P19793 | 5/20 | 0.55 |
| ▸ | RXRB | P28702 | 5/20 | 0.55 |
| ▸ | RXRG | P48443 | 4/20 | 0.55 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.50 |
| ▸ | PGR | P06401 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4092202 | 0.88 | KIF11 (0.71) | KIF11RXRARXRBRXRGTAAR1 | |
| SCHEMBL3785139 | 0.84 | KIF11 (0.65) | KIF11RXRARXRBRXRGTAAR1 | |
| SCHEMBL2320384 | 0.81 | TAAR1 (0.64) | KIF11TAAR1PGRCYP3A4TDP1 | |
| SCHEMBL5123246 | 0.80 | RXRA (0.58) | KIF11RXRARXRBRXRGPGR | |
| SCHEMBL25546726 | 0.79 | KIF11 (0.59) | KIF11RXRARXRBRXRGCYP3A4 | |
| SCHEMBL19331992 | 0.77 | RXRA (0.57) | KIF11RXRARXRBRXRGCYP3A4 | |
| SCHEMBL3787835 | 0.77 | TAAR1 (0.59) | KIF11TAAR1CYP3A4TDP1ALDH1A1 | |
| SCHEMBL28135885 | 0.77 | KIF11 (0.61) | KIF11RXRARXRBRXRGPGR | |
| SCHEMBL2655246 | 0.77 | KIF11 (1.00) | KIF11CYP3A4TDP1ALDH1A1TP53 | |
| SCHEMBL18001905 | 0.77 | RXRA (0.55) | KIF11RXRARXRBRXRGPGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210317092-A1 | TETRAZOLE CONTAINING COMPOUNDS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210317092-A1 | TETRAZOLE CONTAINING COMPOUNDS | TSLP, IL5, TRPA1 | KIF11 3016/4885RXRA 1802/4885RXRB 1753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.